Novavax

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Novavax and other ETFs, options, and stocks.

About NVAX

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. 

CEO
John C.s Jacobs
CEOJohn C.s Jacobs
Employees
952
Employees952
Headquarters
Gaithersburg, Maryland
HeadquartersGaithersburg, Maryland
Founded
1987
Founded1987
Employees
952
Employees952

NVAX Key Statistics

Market cap
1.20B
Market cap1.20B
Price-Earnings ratio
-5.64
Price-Earnings ratio-5.64
Dividend yield
Dividend yield
Average volume
7.74M
Average volume7.74M
High today
$7.81
High today$7.81
Low today
$5.91
Low today$5.91
Open price
$7.00
Open price$7.00
Volume
14.73M
Volume14.73M
52 Week high
$23.86
52 Week high$23.86
52 Week low
$3.90
52 Week low$3.90

NVAX News

Benzinga 8h
Novavax's COVID-19 Vaccine Nears FDA Full Approval, Stock Jumps

Novavax, Inc. NAVX stock traded higher on Wednesday. In an SEC filing, Novavax said, “We believe that our Biologics License Application (BLA) is approvable bas...

Novavax's COVID-19 Vaccine Nears FDA Full Approval, Stock Jumps
TipRanks 15h
Novavax has improved clarity on path forward for Nuvaxovid, says BofA

BofA notes that Novavax (NVAX) shares are up 21% after announcing the company has received communication from the FDA for a post marketing commitment to generat...

Analyst ratings

57%

of 7 ratings
Buy
57.1%
Hold
28.6%
Sell
14.3%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.